Correction: Novel formulations of oral bisphosphonates in the treatment of osteoporosis. (2023)
Attributed to:
Programme 3: Early development and risk of adult musculoskeletal disease
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s40520-022-02319-1
PubMed Identifier: 36595210
Publication URI: http://europepmc.org/abstract/MED/36595210
Type: Journal Article/Review
Volume: 35
Parent Publication: Aging clinical and experimental research
Issue: 6
ISSN: 1594-0667